APA (7th ed.) Citation
(2026). The albumin–bilirubin score predicts outcomes in advanced biliary tract cancer treated with durvalumab immunochemotherapy. The Oncologist.
Chicago Style (17th ed.) Citation
"The Albumin–bilirubin Score Predicts Outcomes in Advanced Biliary Tract Cancer Treated with Durvalumab Immunochemotherapy." The Oncologist 2026.
MLA (9th ed.) Citation
"The Albumin–bilirubin Score Predicts Outcomes in Advanced Biliary Tract Cancer Treated with Durvalumab Immunochemotherapy." The Oncologist, 2026.
Warning: These citations may not always be 100% accurate.